Treatment of autoimmune uveoretinitis in the rat with rapamycin, an inhibitor of lymphocyte growth factor signal transduction
Authors:
- 1 January 1993
- journal article
- research article
- Published by Taylor & Francis in Current Eye Research
- Vol. 12 (2) , 197-203
Abstract
Rapamycin (RAPA) is a macrolide antibiotic with unique immunosuppressive properties. RAPA inhibits T-cell function by interfering with IL-2 and IL-4 signal transduction. It does not prevent IL-2 production or IL-2R expression. The efficacy of RAPA in the treatment of autoimmune diseases was evaluated using the experimental autoimmune uveoretinitis (EAU) model. EAU was actively induced in Lewis rats by immunization with S-antigen in Hunter's adjuvant. RAPA and control vehicle were administered by continuous intravenous infusion over a 14 day period by miniosmotic pump. RAPA treatment initiated on the day of immunization or 7 days later was found to efficiently inhibit EAU induction. The minimal effective dose was 0.1 mg/kg/d. EAU inhibition was correlated with reduced number of cells in the immunization site draining lymph nodes, as well as with a shift and lowering of the peak of the lymphocyte proliferative response curve. The anti-S-antigen antibody response was delayed by 3 days under RAPA treatment and the serum levels lowered in a dose dependent manner. An initial body weight loss was observed during the first week of drug administration, but there was a normal weight gain afterward.Keywords
This publication has 30 references indexed in Scilit:
- A new effective and non-harmful chemical adjuvant for the induction of experimental autoimmune uveoretinitisCurrent Eye Research, 1992
- The effect of rapamycin on renal function in the rat: a comparative study with cyclosporineToxicology Letters, 1991
- TOXICITY OF RAPAMYCIN—A COMPARATIVE AND COMBINATION STUDY WITH CYCLOSPORINE AT IMMUNOTHERAPEUTIC DOSAGE IN THE RATTransplantation, 1991
- The effect of the immunosuppressant FK‐506 on alternate pathways of T cell activationEuropean Journal of Immunology, 1991
- Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.Proceedings of the National Academy of Sciences, 1990
- Suppression of B cell activation by cyclosporin A, FK506 and rapamycinEuropean Journal of Immunology, 1990
- Experimental autoimmune uveoretinitis (EAU) induced by retinal interphotoreceptor retinoid-binding protein (IRBP): Differences between EAU induced by IRBP and by S-antigenClinical Immunology and Immunopathology, 1987
- Renal Histopathologic Alterations in Patients Treated with Cyclosporine for UveitisNew England Journal of Medicine, 1986
- Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A.Journal of Experimental Medicine, 1986
- Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.The Journal of Antibiotics, 1975